Market Brief

The articles are produced in Chinese only.

Author

邱俊瑜先生 (Porter Yau)
經理

主要按基本因素選股,但有時也會參考圖表、技術分析。除股票外,亦經常研究期權 。歡迎來電賜教或交流心得。
Phone:
36517388

中國心連心化肥有限公司 (1866)

Thursday, June 16, 2022 Views6644

中國心連心化肥有限公司 1866.hk

主要從事生產及銷售尿素、複合肥、甲醇、三聚氰胺、糠醇、二甲醚、液態氨及氨溶液。

第一季度 業績盈利預喜

2022 年一季度淨利潤同比增長不低於70%,原因如下:

  1. 規模提升: 21 年3 月九江基地投產、21 年四季度新鄉二三廠改造項目完成,優質產能進一步釋放,技術及規模優勢更加突顯,從而增強了盈利能力;
  2. 優化產品結構:集團借助園區優勢,加強產品柔性調節,優化產品結構,提高高效肥佔比,不斷加大研發推廣力度,進一步增強低成本及產品差異 化優勢,提高市場競爭力,提升利潤空間;
  3. 剛性需求的增長:原材料及糧食價格上漲,推升了農業對化肥剛性需求的增長,從而推動化肥及化工品銷量及價格提升,使本集團主要 產品尿素、三聚氰胺及甲醇受益明顯。

 

先舊後新配售

4 月19 日心連心配售7850 萬股(當中5650 萬股為新股,2200 萬股為舊股),佔公司擴大後股本約6.4%(新股部分佔4.6%),每股配售價格6.5 港元。總共融資約3.6 億港元,融資所得約1.4 億港元用於償還銀行貸款,優化債務結構。另外約2.2 億港元用於甘肅省金昌、江西省九江的項目建設。

 

短評:

俄烏戰爭和糧食危機下,化肥股在2022年初表現出眾。1866.hk股價在發出盈喜下衝上$8.62後公佈配股消息,配股價$6.5;幸好舊股東只係減持22M股,相對配售的78.5M,比例少於3成;現時大股東持股比例約54.5%,相信不會影響未來的發展。

 

由於公司已經發出第一季度的盈喜,只要尿素和複合肥料價格保持平穩,公司擴張式產能將會得益;預計今年每股盈利將有20%增長,每股盈利約$1.6。現時股價$6.09,預期PE只有3.8倍,預期股息5.3%;建議在6元附近收集。但短期需要留意尿素價格的走勢。

 

目標價:$8.8

止損價:$5.4

 

 

This report is produced and is being distributed in Hong Kong by Phillip Securities Group with the Securities and Futures Commission (“SFC”) licence under Phillip Securities (HK) LTD and/ or Phillip Commodities (HK) LTD (“Phillip”). Information contained herein is based on sources that Phillip believed to be accurate. Phillip does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The information is for informative purposes only and is not intended to or create/induce the creation of any binding legal relations. The information provided do not constitute investment advice, solicitation, purchase or sell any investment product(s). Investments are subject to investment risks including possible loss of the principal amount invested. You should refer to your Financial Advisor for investment advice based on your investment experience, financial situation, any of your particular needs and risk preference. For details of different product's risks, please visit the Risk Disclosures Statement on http://www.phillip.com.hk. Phillip (or employees) may have positions/ interests in relevant investment products. Phillip (or one of its affiliates) may from time to time provide services for, or solicit services or other business from, any company mentioned in this report. The above information is owned by Phillip and protected by copyright and intellectual property Laws. It may not be reproduced, distributed or published for any purpose without prior written consent from Phillip.
Top of Page
Contact Us
Please contact your account executive or call us now.
Research Department
Tel : (852) 2277 6846
Fax : (852) 2277 6565
Email : businessenquiry@phillip.com.hk

Enquiry & Support
Branches
The Complaint Procedures
About Us
Phillip Securities Group
Join Us
Phillip Network
Phillip Post
Phillip Channel
Latest Promotion
E-Check
Login
Investor Notes
Free Subscribe
Contact Us